FinDM database on diabetes in Finland

............................................................................................................................................................................................ 2

[1]  U. Puistola,et al.  Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes , 2019, Breast Cancer Research and Treatment.

[2]  P. Groop,et al.  Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study , 2019, Diabetes Care.

[3]  E. Urpilainen,et al.  The role of metformin and statins in ovarian and breast cancer in women with type 2 diabetes , 2019 .

[4]  R. Arima.  Metformin, statins and the risk and prognosis of endometrial cancer in women with type 2 diabetes , 2019 .

[5]  T. Ninomiya.  Epidemiological Evidence of the Relationship Between Diabetes and Dementia. , 2019, Advances in experimental medicine and biology.

[6]  A. But.  Mitigating bias and dealing with multiple time scales in cohort studies : Studying medications and complications of diabetes , 2018 .

[7]  T. Ahluwalia,et al.  Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy , 2018, Diabetes Care.

[8]  L. Niskanen,et al.  Excess mortality in Finnish diabetic subjects due to alcohol, accidents and suicide: a nationwide study , 2018, European journal of endocrinology.

[9]  V. Salomaa,et al.  Regional differences in the incidence of diabetic cardiovascular events reflect the quality of care , 2018, Scandinavian cardiovascular journal : SCJ.

[10]  P. Ilanne-Parikka,et al.  Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study , 2018, BMC Cancer.

[11]  P. Ilanne-Parikka,et al.  Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes , 2018, AntiCancer Research.

[12]  P. Ilanne-Parikka,et al.  The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case–control study , 2018, BJOG : an international journal of obstetrics and gynaecology.

[13]  Till Bärnighausen,et al.  Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 , 2018, Diabetes Care.

[14]  H. Storm,et al.  Nordic Cancer Registries – an overview of their procedures and data comparability , 2017, Acta oncologica.

[15]  L. V. Velde.  Missing links in the genesis of type 1 diabetes : A geographical approach to the case of enteroviruses in the Nordic region , 2018 .

[16]  P. Groop,et al.  Incidence of end-stage renal disease in patients with type 1 diabetes. , 2005, Journal of the American Medical Association (JAMA).

[17]  P. Ilanne-Parikka,et al.  Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication. , 2017, Gynecologic oncology.

[18]  R. Sund,et al.  Lonkkamurtumariski diabetesta sairastavilla , 2017 .

[19]  L. Moilanen,et al.  Working people with type 1 diabetes in the Finnish population , 2017, BMC Public Health.

[20]  P. Ilanne-Parikka,et al.  Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes. , 2017, Gynecologic oncology.

[21]  U. Häkkinen,et al.  Diabetes pääkaupunkiseudulla - potilasmäärät, kustannukset ja lisäkustannukset , 2017 .

[22]  E. Mayer-Davis,et al.  Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. , 2017, The New England journal of medicine.

[23]  R. Sund,et al.  Multiple complications among people with diabetes from Finland: an 18-year follow-up in 1994–2011 , 2016, BMJ Open Diabetes Research and Care.

[24]  K. Winell,et al.  Regional trends in avoidable hospitalisations due to complications among population with diabetes in Finland in 1996−2011: a register-based cohort study , 2016, BMJ Open.

[25]  S. Wild,et al.  Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals , 2016, Diabetologia.

[26]  Merlin C. Thomas,et al.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease , 2016, Nature Reviews Nephrology.

[27]  P. Ruokoniemi.  From statin efficacy to everyday effectiveness: Studying the gap in between. , 2015 .

[28]  J. Lindström,et al.  Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972–2007 , 2015, European Journal of Epidemiology.

[29]  Marc Suhrcke,et al.  The Economic Costs of Type 2 Diabetes: A Global Systematic Review , 2015, PharmacoEconomics.

[30]  A. Hofman,et al.  Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis , 2015, Diabetologia.

[31]  Yoshimasa Tanaka,et al.  Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention , 2014, International journal of medical sciences.

[32]  M. Toh,et al.  Cost-of-illness studies of diabetes mellitus: a systematic review. , 2014, Diabetes research and clinical practice.

[33]  J. Helve,et al.  Survival of patients with type 1 diabetes on renal replacement therapy , 2014 .

[34]  R. Huupponen,et al.  Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland , 2014, BMJ Open.

[35]  P. Groop,et al.  Medication among patients with type 1 diabetes and predialytic renal disease. , 2014, Diabetes research and clinical practice.

[36]  K. Winell,et al.  Diabeteksen komplikaatioiden estäminen on onnistunut vain osittain , 2014 .

[37]  Sairaanhoidon kustannuksiin alueellisesti vaikuttavat tekijät tyypin 2 diabeetikoilla Suomessa vuonna 2007 , 2014 .

[38]  M. Venermo,et al.  Indicators for comparing the incidence of diabetic amputations: a nationwide population-based register study. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[39]  P. Ilanne-Parikka,et al.  Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study , 2013, BMJ Open.

[40]  R. Sund,et al.  Methodological challenges in international performance measurement using patient-level administrative data. , 2013, Health policy.

[41]  M. Jokela,et al.  Treatment of depression in diagnosed diabetes: common cause or detection bias? , 2013, Psychological Medicine.

[42]  M. Knip,et al.  Incidence of type 1 diabetes in Finland. , 2013, JAMA.

[43]  M. Venermo,et al.  Fewer Major Amputations Among Individuals With Diabetes in Finland in 1997-2007 A population-based study , 2013 .

[44]  K. Winell.  The Epidemiology of Macrovascular Complications of Diabetes in Finland 1992-2002 , 2013 .

[45]  M. Venermo,et al.  Amputations and socioeconomic position among persons with diabetes mellitus, a population-based register study , 2013, BMJ Open.

[46]  C. Lloyd,et al.  Epidemiology of depression and diabetes: a systematic review. , 2012, Journal of affective disorders.

[47]  I. Keskimäki,et al.  Socio-economic predictors of mortality among diabetic people. , 2012, European journal of public health.

[48]  V. Salomaa,et al.  Trends in population attributable fraction of acute coronary syndrome and ischaemic stroke due to diabetes in Finland , 2011, Diabetologia.

[49]  R. Sund,et al.  Pathways leading to coronary revascularisation among patients with diabetes in Finland: a longitudinal register-based study , 2011, BMC health services research.

[50]  K. Borch-Johnsen,et al.  The National Diabetes Register , 2011, Scandinavian journal of public health.

[51]  M. Elovainio,et al.  Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997–2007 , 2011, Pharmacoepidemiology and drug safety.

[52]  V. Salomaa,et al.  Prognosis of Ischaemic Stroke is Improving Similarly in Patients with Type 2 Diabetes as in Nondiabetic Patients in Finland , 2011, International journal of stroke : official journal of the International Stroke Society.

[53]  R. Sund,et al.  Sepelvaltimotaudin riskitekijöiden lääkehoito on tehostunut diabeetikoilla , 2011 .

[54]  M. Venermo,et al.  Fewer Major Amputations Among Individuals With Diabetes in Finland in 1997–2007 , 2010, Diabetes Care.

[55]  A. Reunanen,et al.  Socioeconomic differences in mortality among diabetic people in Finland , 2010, Scandinavian journal of public health.

[56]  A. Reunanen,et al.  Increasing resources effected equity in access to revascularizations for patients with diabetes , 2010, Scandinavian cardiovascular journal : SCJ.

[57]  A. Reunanen,et al.  Changing patterns of secondary preventive medication among newly diagnosed coronary heart disease patients with diabetes in Finland: A register-based study , 2010, Scandinavian journal of public health.

[58]  V. Salomaa,et al.  Case fatality rates after first acute coronary syndrome in persons treated for type 2 diabetes show an improving trend , 2010, Diabetologia.

[59]  Coronary heart disease among diabetic and nondiabetic people - socioeconomic differences in incidence, prognosis and mortality. , 2008, Journal of diabetes and its complications.

[60]  K. Winell,et al.  The national hospital discharge register data on lower limb amputations. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[61]  Marjaana Niemi,et al.  Diabetes Suomessa : Esiintyvyys ja hoidon laadun vaihtelu , 2005 .

[62]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[63]  L. Gaal,et al.  Assessing the impact of complications on the costs of Type II diabetes , 2002, Diabetologia.

[64]  A. Hautamäki,et al.  The national research and development centre for welfare and health. , 1993 .

[65]  M. McCloy.  The Queen's University of Belfast , 2013, Nature.